RPRX
NASDAQStockRoyalty Pharma plc
$46.12-0.57 (-1.22%)
52-Week Range
$30.85
$47.48
Key Stats
Market Cap
19.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.42
Volume
2.4M
Avg Volume
3.3M
Performance
1M
+3.75%
3M
+19.48%
6M
+30.50%
YTD
+18.04%
1Y
+39.63%
3Y
+39.98%
5Y
-2.07%
Price Chart
ETF Exposure
RPRX is held by 188 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IHE | iShares U.S. Pharmaceuticals ETF | 4.50% |
| VFLO | VictoryShares Free Cash Flow ETF | 3.17% |
| PBE | Invesco Biotechnology & Genome ETF | 2.90% |
| OUSM | ALPS Funds O’Shares U.S. Small-Cap Quality Dividend ETF | 2.61% |
| IPO | Renaissance IPO ETF | 2.56% |
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 2.33% |
| AUSF | Global X - Adaptive U.S. Factor ETF | 2.20% |
| SMOT | VanEck Morningstar SMID Moat ETF | 1.74% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 1.49% |
| FCPI | FIDELITY STOCKS FOR INFLATION ETF | 1.33% |
| VFMV | Vanguard U.S. Minimum Volatility ETF | 1.21% |
| COWG | Pacer US Large Cap Cash Cows Growth Leaders ETF | 1.19% |
| FDLS | Inspire Fidelis Multi Factor ETF | 1.14% |
| CVY | Invesco Zacks Multi-Asset Income ETF | 1.05% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 1.04% |
| STLC | iShares Trust - iShares Factors US Blend Style ETF | 1.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 1.02% |
| INFL | Horizon Kinetics Inflation Beneficiaries ETF | 1.00% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 1.00% |
| FPX | First Trust US Equity Opportunities ETF | 0.81% |
| FLRG | FIDELITY U.S. MULTIFACTOR ETF | 0.77% |
| FLQM | Franklin U.S. Mid Cap Multifactor Index ETF | 0.73% |
| DVAL | BrandywineGLOBAL-Dynamic US Large Cap Value ETF | 0.65% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.63% |
| PABU | iShares Paris-Aligned Climate Optimized MSCI USA ETF | 0.61% |
| ONEY | State Street SPDR Russell 1000 Yield Focus ETF | 0.58% |
| FFLC | FIDELITY FUNDAMENTAL LARGE CAP CORE ETF | 0.55% |
| NZUS | State Street SPDR MSCI USA Climate Paris Aligned ETF | 0.55% |
| QLC | FlexShares US Quality Large Cap Index Fund | 0.54% |
| DEUS | Xtrackers Russell US Multifactor ETF | 0.54% |
| ONEV | State Street SPDR Russell 1000 Low Volatility Focus ETF | 0.53% |
| FTHI | First Trust BuyWrite Income ETF | 0.52% |
| FXH | First Trust Health Care AlphaDEX Fund | 0.51% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.46% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.42% |
| LOPP | Gabelli Love Our Planet & People ETF | 0.40% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.39% |
| ONEO | State Street SPDR Russell 1000 Momentum Focus ETF | 0.37% |
| BSCV | Invesco BulletShares 2031 Corporate Bond ETF | 0.36% |
| FTQI | First Trust Nasdaq BuyWrite Income ETF | 0.36% |
| SCHM | Schwab U.S. Mid-Cap ETF | 0.36% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.35% |
| STMB | iShares Trust - iShares Factors US Mid Blend Style ETF | 0.34% |
| LGCF | Themes US Cash Flow Champions ETF | 0.33% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.33% |
| BSCZ | Invesco BulletShares 2035 Corporate Bond ETF | 0.32% |
| IYH | iShares U.S. Healthcare ETF | 0.31% |
| OMFL | Invesco Russell 1000 Dynamic Multifactor ETF | 0.29% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.29% |
| BLES | Inspire Global Hope ETF | 0.28% |
Page 1 of 4Next
About RPRX ETF Exposure
Royalty Pharma plc (RPRX) is held by 188 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 19.8B, RPRX is a widely held institutional stock. The stock currently trades at $46.12. Investors can gain exposure to RPRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RPRX, sorted by portfolio weight.